Morgan Stanley Yumanity Therapeutics, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.99 $376 - $734	-369 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.97 - $3.27 $357 - $1,206	369 New	369 $1,000
Q1 2022 May 13, 2022	SELL	$0.97 - $3.27 $7,517 - $25,342	-7,750 Reduced 95.46%	369 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.81 - $10.48 $22,603 - $84,301	8,044 Added 10725.33%	8,119 $24,000
Q3 2021 Nov 15, 2021	BUY	$8.3 - $12.04 $622 - $902	75 New	75 $1,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.